269 related articles for article (PubMed ID: 38292478)
1. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
[TBL] [Abstract][Full Text] [Related]
2. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
4. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia.
Li Q; Wang M; Liu L
Biochem Pharmacol; 2023 Jun; 212():115539. PubMed ID: 37024061
[TBL] [Abstract][Full Text] [Related]
5. RNA trafficking by acute myelogenous leukemia exosomes.
Huan J; Hornick NI; Shurtleff MJ; Skinner AM; Goloviznina NA; Roberts CT; Kurre P
Cancer Res; 2013 Jan; 73(2):918-29. PubMed ID: 23149911
[TBL] [Abstract][Full Text] [Related]
6. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
[TBL] [Abstract][Full Text] [Related]
7. Exosomes in acute myeloid leukemia inhibit hematopoiesis.
Boyiadzis M; Whiteside TL
Curr Opin Hematol; 2018 Jul; 25(4):279-284. PubMed ID: 29846239
[TBL] [Abstract][Full Text] [Related]
8. EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
Zhou Q; Li Z; Xi Y
Exp Hematol; 2024 May; 133():104175. PubMed ID: 38311165
[TBL] [Abstract][Full Text] [Related]
9. Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.
Serroukh Y; Hébert J; Busque L; Mercier F; Rudd CE; Assouline S; Lachance S; Delisle JS
Blood Rev; 2023 Jan; 57():100991. PubMed ID: 35941029
[TBL] [Abstract][Full Text] [Related]
10. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival.
Miyamoto KN; Bonatto D
Clin Immunol; 2020 Aug; 217():108489. PubMed ID: 32492479
[TBL] [Abstract][Full Text] [Related]
11. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
12. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia.
Salehi A
Med Oncol; 2024 Jan; 41(2):62. PubMed ID: 38253748
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.
Hong CS; Muller L; Boyiadzis M; Whiteside TL
PLoS One; 2014; 9(8):e103310. PubMed ID: 25093329
[TBL] [Abstract][Full Text] [Related]
14. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819
[TBL] [Abstract][Full Text] [Related]
15. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
16. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
[TBL] [Abstract][Full Text] [Related]
17. Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes.
Kargar-Sichani Y; Mohammadi MH; Amiri V; Barzegar M; Keshavarz A; Bashash D; Farsani MA
Arch Med Res; 2023 Feb; 54(2):95-104. PubMed ID: 36717322
[TBL] [Abstract][Full Text] [Related]
18. The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities.
Mudgapalli N; Nallasamy P; Chava H; Chava S; Pathania AS; Gunda V; Gorantla S; Pandey MK; Gupta SC; Challagundla KB
Mol Aspects Med; 2019 Dec; 70():21-32. PubMed ID: 31623866
[TBL] [Abstract][Full Text] [Related]
19. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
20. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
